Delivery Order SPE2DB24D2018-SPE2DB25FWWC9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,135.84 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 25, 2025, with completion scheduled for August 26, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.76 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,007.81 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on June 25, 2025, with completion scheduled for June 26, 2025. This firm fixed price, non-set-aside delivery order represents a continuation of federal medical supply procurement through the company's existing contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded a $3,093.60 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed price contract. This non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a $1,525.72 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 28, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Dexcom G7 sensors, with a ceiling value of $1,787.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 15, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive federal medical supply relationship with DLA, leveraging the company's established...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price, non-competitive delivery order is being performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWC9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,120.37 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and is particularly active in supplying medical devices and pharmaceuticals to military and veteran healthcare systems through DLA's Medical Supply Chain. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's prime IDC with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The Dexcom G7 sensors—continuous glucose monitoring devices—support federal healthcare initiatives for military personnel and beneficiaries managing diabetes. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, positioning the company as a key component of the Defense Logistics Agency's pharmaceutical and medical device distribution infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/8/25 |